Cargando…
Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury
Autores principales: | Wang, Wei, Yang, Penghui, Zhong, Ying, Zhao, Zhongpeng, Xing, Li, Zhao, Yan, Zou, Zhen, Zhang, Yanli, Li, Chenggang, Li, Taisheng, Wang, Chen, Wang, Zhong, Yu, Xuezhong, Cao, Bin, Gao, Xiang, Penninger, Josef M, Wang, Xiliang, Jiang, Chengyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616436/ https://www.ncbi.nlm.nih.gov/pubmed/23419516 http://dx.doi.org/10.1038/cr.2013.25 |
Ejemplares similares
-
CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats
por: Lang, Shan, et al.
Publicado: (2017) -
An IP-10 (CXCL10)-Derived Peptide Inhibits Angiogenesis
por: Yates-Binder, Cecelia C., et al.
Publicado: (2012) -
Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
por: Rabquer, Bradley J, et al.
Publicado: (2011) -
Characterization of the 2009 Pandemic A/Beijing/501/2009 H1N1 Influenza Strain in Human Airway Epithelial Cells and Ferrets
por: Yang, Penghui, et al.
Publicado: (2012) -
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications
por: Liu, Mingli, et al.
Publicado: (2011)